Carol A Starks MS, MLS(ASCP), CLS. castarks
|
|
- Claude Perkins
- 6 years ago
- Views:
Transcription
1 Carol A Starks MS, MLS(ASCP), CLS
2 Brief review of the common blood groups ABO Rh Kell Duffy Kidd P Lutheran MNS Lewis
3 Basic Blood Bank workups ABO discrepancies Single antibody not demonstrating Single antibody Multiple Antibodies Cold Warm Auto Antibodies High Frequencies Low Frequencies
4 Genotype Phenotype Homozygous Heterozygous Dosage AHG (aka IAT) IS Clinically Significant (HTRs or HDFN)
5
6 ABO Antigens begin to appear on fetal RBCs at weeks gestation; reach adult levels by age 4. ABO antigens are found on endothelium, kidney, heart, lung, bowel, and pancreatic tissues.
7 CLINICALLY SIGNIFICANT Naturally occurring Appear at age 4 months; and reach adult levels by age 10. Levels may fade with advanced age.
8 Generally IgM class antibodies For Group A and Group B persons the predominant antibody class is IgM For Group O people the dominant antibody class is IgG (with some IgM) React best at room temperature (22-24 o C) or below in vitro. Activates complement to completion at 37 o C Can cause acute Hemolytic Transfusion reactions RBC Immune form: Predominantly IgG
9 They both react strongly with reagent anti-a. 80% of group A individuals phenotype as A1 20% phenotype as A2 Reagent anti-a is a mixture of two Abs ; anti-a which react with both A1 and A2 cells. anti-a1 which reacts with A cells but not with A2 cells in simple testing.
10 Differentiation between the A blood subgroups Reagent anti-a is a mixture of two Abs The two Abs can be functionally separated by adsorption with A2 cells. Anti-A1-lectin: is another source of anti-a1. lectins are seed extracts that agglutinate human cells with some degree of specificity. The seeds of the plant Dolichos biflorus serve as the source of the anti-a1 lectin; this reagent agglutinates A1 or A1B cells but does not agglutinate A2 or A2B cells.
11 Other A subgroups: RBC of the A int, A 3, Ax, A y or A cl. are only rarely seen in transfusion practice. Subgroup of B: infrequent than the weaker subgroup of A, identified by anti-b and anti-a,b. Subgroups B3, Bx, Bm and Bcl.
12 ABO discrepancies happen when there is no match in results between forward and reverse grouping. ABO discrepancies are usually technical in nature and can be simply resolved by correctly reporting the testing and carefully checking reagents with meticulous reading and recording of results.
13 There are some ABO discrepancies that can happen due to technical errors and may lead to false positive or false negative reactions. False positive reactions are due to; Un-calibrated centrifuges Contaminated reagents Dirty tubes or glassware
14 False negative reactions can be due to many causes Failure to add serum or reagents Use of incorrect reagents or samples Cell suspension is too heavy or too light Inadequate identification of samples or test tubes
15 Group I discrepancies These discrepancies are between forward and reverse grouping due to weak reaction or missing antibodies. These kind of discrepancies are the most common. The reason for the missing antibody or weak reaction is that the patient has depressed antibody production or cannot produce the ABO antibodies.
16 Resolving discrepancies Eliminate all technical errors Enhancing the reaction in reverse grouping Incubate the patient s serum with reagent cells at room temp. for 15 mins. Increase serum to cell ratio in the reverse typing.
17 Anti-A Anti-B Anti-D A cells B cells Interpretation History ? O pos This type of discrepancy can be seen in new born infants, elderly patients. Patients with lymphoma. Patients using immunosuppressive drugs. Patients with immunodeficiency disease, BM transplant.
18 Group II discrepancies These discrepancies are between forward and reverse grouping due to weak reaction or missing antigens. These discrepancies are the least frequent. Can be caused by some subgroups of A or subgroups of B or both. Also it can be present in patients with leukemia and Hodgkin's disease. To resolve the problem wash the patient s cells with saline.
19 42 year old man, with a historical type AB+ Anti-A Anti-B Anti-D A cells B cells Interpretation History ? AB Pos Where is the problem here? What do you think went wrong? What do you do next Missing Antigens! I made a mistake, repeat Get a history
20 History told us this patient was recently transfused with multiple units of O positive and A positive RBCs. There were a total of 12 units over the last 6 days. This would be considered indeterminate due to recent transfusions. What would future transfusions look like?
21 Group III discrepancies These discrepancies are between forward and reverse grouping due to protein or plasma abnormalities. These can be caused by elevated levels of globulin from certain diseases such as multiple myeloma, Hodgkin's lymphoma. Some are caused by (Rouleaux formation).
22 Rouleaux or red cells result from a stacking of erythrocytes that adhere in a coin-link fashion giving the appearance of agglutination. To resolve this kind of problem, washing the patient s red cells with saline or adding a drop or two of saline to the tube in case of rouleaux formation. If the agglutination is true red cell clumping will remain. Cord blood must be washed 6-8 times in forward grouping ONLY. This is to remove the Wharton s jelly.
23 Anti-A Anti-B Anti-D A cells B cells Interpretation History ? A pos Saline Replacement Anti-A Anti-B Anti-D A cells B cells Interpretation History A pos A pos
24
25 Group IV discrepancies These kind of discrepancies are between forward and reverse groping due to miscellaneous problems. Polyagglutination can occur due to exposure of hidden erythrocyte Ag. (T antigen) in patients with bacterial or viral infection. Bacterial contamination in vitro or vivo produces an enzyme that alters and exposes the hidden Ag. on red cell leading to T activation.
26 Second most important blood group after the ABO system. Terminology Fisher Race (DCE or CDE) Wiener (R 1, r 1, etc.) D type is determined by the presence of the D antigen.
27 Require exposure Warm Reacting D induces the most antibodies, then c and E. HTR with extravascular hemolysis Severe HDFN with anti-d, anti-c, and mild HDFN with anti-c, E, e. Due to the mosaic and weak features of the D antigen, can have some weird stuff.
28 Clinically and serologically important group. Antigens in the system: K, k, Jsa, Jsb, Kpa, and Kpb. Low frequencies: K, Jsa, and Kpa High frequencies: k, Jsb, Kpb Kell antigens destroyed by Thiol reagents. DTT ZZAP
29 Require Exposure Typically transfusion Warm reacting IgG Can cause severe HTR Severe HDFN, with lower bilirubin and retic levels. Attacks early RBC precursors.
30 Consist of Fya and Fyb antigens. FYA high frequency in the Asian population FYB high frequency in the Caucasian population. Fya neg and Fyb neg most common phenotype in African Americans. (gives protection from malaria(vive))
31 Exposure required Warm reacting; IgG Decreased activity with Ficin (enzymes). Marked dosage and can show variability in reactions. Severe HTR, delayed and extravascular usually Often mild but can be severe HDFN.
32 Antigens Jka, Jkb, Jk3. Jk3 very high frequency
33 Require exposure. Warm reacting, IgG, often with an IgM component as well. Can fix complement with the IgM component. Severe acute HTN possible. Demonstrate marked dosage. Variable expression, and will disappear with time/storage. Known for delayed HTN, that can be severe and intravascular. Kidds play hide and seek.
34 Antigens P1 and Pk Antibodies Cold reacting, IgM Naturally occurring Insignificant Neutralized by H. cyst fluid, or pigeon egg whites. Auto anti-p (PCH) Biphasic IgG that binds in the cold and then hemolyzed when warmed. Give full crossmatch compatible typically.
35 Antigens Lua and Lub Lua is a low frequency Lub is a very high frequency Antibodies Uncommon, may be naturally occurring Not usually significant Decreased activity by enzymes Typically give full crossmatch compatible.
36 Antigens M, N, S, s. M roughly equals N in prevalence ( 75%) s is more frequent than S. S-s- individuals may also be U-. U is a high frequency antigen. These individuals can make Anti-U.
37 M and N are almost the opposite of S and s. Anti-M and Anti-N Naturally occurring Cold reacting, IgM Dosage Insignificant Anti-S and Anti-s Require exposure Warm IgG Minimal Dosage Significant M and N can be ignored unless they react at 37. Rarely associated with severe HDFN.
38 Coded for one gene Le. (like D) Le will add a fucose to the GlcNAc resulting in Lea. Secretors will add another fucose resulting in Leb Formation of Leb is preferential in secretors. Antigens are not tightly bound, rather they are absorbed onto the service of the RBCs.
39 Pregnancy Antigen levels decrease due to change of composition of patients plasma. Can give rise to transient Lewis antibodies Lea-Leb+ do not develop Anti-Lea Children s Lewis typing will change as chains are converted. Lea+Leb+ will change to Lea-Leb+ Associated Infections: H Pylori attaches via Leb Lea-Leb- more susceptible to Candida and E coli.
40 Antibodies are typically insignificant. Rare HTR Minimal to no HDFN (does not cross placenta)
41
42 When do we perform an antibody identification. When testing suggests a new antibody (warm autos) To confirm a previously identified antibody (per facility SOP)
43 Basically just a larger antibody. Uses reagent O cells from 8 20 donors Results are documented on a sheet called an antigram. The antigram is a roadmap that outlines every cell s phenotype.
44 Antigram Geography
45 Having a CONSISTENT approach to antibody workups minimizes error. Most workups are simple but cutting corners increases risk for dumb mistakes. Use this or your own system, but to the same approach EVERY TIME!
46 Check history Check Autocontrol Look at general pattern Look at what is NOT there(cross outs)(rule outs) Look at what is there Use special techniques if needed Ensure statistical significance.
47 Check history Check Autocontrol Look at general pattern Look at what is NOT there(cross outs)(rule outs) Look at what is there Use special techniques if needed Ensure statistical significance.
48 History can give you a clue and keep you from doing something dumb. Up to 70% of cases are impacted by history.
49 Anti-D in a pregnant patient Recent bacterial infection treated with antibiotics that cause warm auto Recent transfusion ITP Racial significance African Americans lack Duffy Ags Asians: RARELY D- Caucasian: May lack high freq. Ags Previous Ab and/or phenotyping.(kidds) Transplants
50 Check history Check Autocontrol Look at general pattern Look at what is NOT there(cross outs)(rule outs) Look at what is there Use special techniques if needed Ensure statistical significance.
51 Ask 2 questions: Is DAT positive What is the patient s history Possibilities include: Autoantibodies (warm or cold) Recent transfusion; delayed hemolytic reaction Drug induced Passively acquired antibodies
52 Check history Check Autocontrol Look at general pattern Look at what is NOT there(cross outs)(rule outs) Look at what is there Use special techniques if needed Ensure statistical significance.
53 Are the reactions. Uniform or variable Uniform reactions suggest a single antibody Variable reactions suggest multiple antibodies or a single antibody with dosage. Against all, most, or rare cells A mixture of positive and negative cells suggest a single antibody or multiple alloantibodies(auto neg) A single alloantibody cells suggest a low frequency. All cells reactive suggests multiple alloantibodies or a high frequency. Present at what phases
54 Check history Check Autocontrol Look at general pattern Look at what is NOT there(cross outs)(rule outs) Look at what is there Use special techniques if needed Ensure statistical significance.
55 First approach to the interpretation of the panel results. Once results have been recorded on the antigram, the antigen profile of the first negative cell is examined. If the antigen is present on the reagent red cell and the serum/plasma did not react; presence of the antibody can be excluded. This approach often identifies simple antibodies, and should be considered only as a provisional step; particularly if the rule outs are performed on heterozygous expression. This gives explanation why many SOPs will ask for homozygous expression for rule outs when possible. If not possible use 3 heterozygous cells. From the AABB Technical Manual 17 th ed. Page 470.
56 Check history Check Autocontrol Look at general pattern Look at what is NOT there(cross outs)(rule outs) Look at what is there Use special techniques if needed Ensure statistical significance.
57 First try for a single antibody that will explain all the reactions. If that does not work Hypothesize Two antibodies in the same phase. One warm and one cold antibody Additional reagent cells from another panel maybe ran to help with multiple antibodies and solidifying hypothesis.
58 Check history Check Autocontrol Look at general pattern Look at what is NOT there(cross outs)(rule outs) Look at what is there Use special techniques if needed Ensure statistical significance.
59 Providing your patient has not been transfused in the last 90 days you can phenotype the patient to help provide some resolution. Some other special techniques performed at reference labs typically: Adsorption Elution Proteolytic enzymes (DTT, ZZAP)
60 Check history Check Autocontrol Look at general pattern Look at what is NOT there(cross outs)(rule outs) Look at what is there Use special techniques if needed Ensure statistical significance.
61 Traditional Interpretation: Rule of 3s Ag present and 3 positive reactions Ag absent and 3 negative reactions 95% confidence If you bump this up to 3 and 4 your confidence is 98% This may also require additional cells to be performed to achieve confidence. Has to be done for each individual Ag.
62 Antigen type your patient for the antigen corresponding to the Ab identified. Your patient should be negative. Antigen type most units to be transfused. Insignificant Abs typically only require a full crossmatch. Refer to your facility SOP. If you are low on anti-sera for Ag typing. You can use your patient s plasma/serum to perform the full crossmatch first, then Ag type.
63
64
Georgia Spanos, MT LifeSouth Community Blood Centers Gainesville, Fl. SEABB March 2017
Georgia Spanos, MT LifeSouth Community Blood Centers Gainesville, Fl. SEABB March 2017 Case Study 1 Patient Demographics -44 year old -African-American Female -Diagnosis: Gastroenteritis -Facility reported
More informationVal Tunnard Sheffield RCI. Red Cell Immunohaematology
Val Tunnard Sheffield RCI Produced by the immune system Created in response to a foreign antigen Protein (Immunoglobulins) in serum/plasma Red cell antibodies are either: IgG, 2 binding site IgM, 10 binding
More informationRed Cell Immunohaematology. Mark Dwight Specialist Biomedical Scientist RCI Filton
Red Cell Immunohaematology Mark Dwight Specialist Biomedical Scientist RCI Filton The RCI Laboratories Red Cell Immunohaematology Reference laboratories supporting hospital blood banks in England. RCI
More informatione-grips Module 18 Introduction to Antibody Identification
Introduction to Antibody Identification Introduction Objectives After completing the learning module, the learner will be able to: 1. Discuss the limitations of antibody detection and identification. 2.
More informationAin t Nobody Got Time for
Ain t Nobody Got Time for DATs Lindsay Peters MLS(ASCP)SBB Reference Laboratory Supervisor Mississippi Valley Regional Blood Center OBJECTIVES Define and describe the antiglobulin test. Identify the reagents
More informationABO Typing Discrepancies
Jayme Heimonen MT(ASCP)SBB Blood Bank Technical Specialist Borgess Medical Center Kalamazoo, MI ASCLS-Michigan 2016 1 Expected reactions are missing 4+ 0 4+ 0 0 0 0 0 4+ 0 0 3+ 2 Unexpected reactions are
More informationABO Blood Group 9/13/2015 NAHLA BAKHAMIS MSC 1
ABO Blood Group NAHLA BAKHAMIS MSC. 9/13/2015 NAHLA BAKHAMIS MSC 1 Glossary Chromosome Gene Locus Allele Heterozygous Homozygous Phenotype Genotype Sex Chromosomes Autosomal Chromosomes Dominant Gene Recessive
More informationCompatibility Testing. Compatibility testing is performed to determine if a particular unit of blood can be transfused safely into a certain patient.
Compatibility Testing Compatibility testing is performed to determine if a particular unit of blood can be transfused safely into a certain patient. This includes ABO-Rh blood typing, antibody screening
More informationGroup A, B, Oh No! When there is an ABO typing discrepancy CYNTHIA CRUZ, MLS(ASCP) CM American Red Cross Reference
Group A, B, Oh No! When there is an ABO typing discrepancy CYNTHIA CRUZ, MLS(ASCP) CM American Red Cross Reference Objectives To correlate the forward ABO typing with the reverse ABO typing Determine where
More informationSkills: 20 points. Objectives:
Exercise 5 Type and Screen Skills: 20 points Objectives: 1. List three situations in which screening for unexpected antibodies should be performed. 2. List two patient populations who are candidates for
More informationAntibody - Antigen Reactions: ABO and D typing Antibody screening and identification
Antibody - Antigen Reactions: ABO and D typing Antibody screening and identification Basics of antigen/ antibody reactions Why is the ABO group so special? D antigen it s complicated! Antibody screen Antibody
More informationAlgorithm for the Resolution of Discrepancies of the ABO System
Algorithm for the Resolution of Discrepancies of the ABO System Presented by Dra. Denise Harmening Director of Instruction & Customer Learning American Red Cross, Heritage Division Professor, Department
More informationPRETRANSFUSION OR COMPATIBILITY TESTING
13 PRETRANSFUSION OR COMPATIBILITY TESTING 13.1 INTRODUCTION Pretransfusion compatibility testing serves to select a compatible unit of blood for the recipient which when transfused does not cause any
More informationUse and Abuse of Reagents and Techniques. Joann Moulds PhD, MT(ASCP)SBB Director, Scientific Support Services LifeShare Blood Centers Shreveport, LA.
Use and Abuse of Reagents and Techniques Joann Moulds PhD, MT(ASCP)SBB Director, Scientific Support Services LifeShare Blood Centers Shreveport, LA. Antibody Screening & Identification Blood Grouping Reference
More informationSTANDARD OPERATING PROCEDURE FOR ANTIBODY IDENTIFICATION - TUBE METHOD
STANDARD OPERATING PROCEDURE FOR ANTIBODY IDENTIFICATION - TUBE METHOD TITLE: STANDARD OPERATING PROCEDURE FOR ANTIBODY IDENTIFICATION TUBE METHOD 1.0 Principle An antibody identification procedure is
More informationCLINICAL SIGNIFICANCE:
Subject Crossmatch Procedure Gel Method Index Number Lab-8769 Section Laboratory Subsection Regionals/Affiliates Category Departmental Contact Rachel Blum Last Revised 9/7/2017 References Required document
More informationTable of Contents. Preface... xv. Editorial Comments... xvii. About the Authors... xix
Preface................................................................... xv Editorial Comments........................................................ xvii About the Authors..........................................................
More informationApplications of Red Cell Genotyping in Serological Problem-Solving
Applications of Red Cell Genotyping in Serological Problem-Solving Philippe P Pary RT, MT(ASCP)SBB Transfusion Medicine Children s National Health System Molecular vs Serological Phenotypes Serological
More information6/15/2015. Molecular vs Serological Phenotypes. Molecular vs Serological Phenotypes. Molecular Phenotyping Advantages
Applications of Red Cell Genotyping in Serological Problem-Solving Philippe P Pary RT, MT(ASCP)SBB Transfusion Medicine Children s National Health System Molecular vs Serological Phenotypes Serological
More informationAntibody Identification: Art or Science? A Case Study Approach
Antibody Identification: Art or Science? A Case Study Approach (Questions and Answers) Editors Janis R. Hamilton, MS, MT(ASCP)SBB Susan T. Johnson, MSTM, MT(ASCP)SBB Sally V. Rudmann, PhD, MT(ASCP)SBB
More informationMechanisms of extravascular destruction of red cells coated with IgG1 or IgG3 (± C3b).
Introduction - Antibodies involved in transfusion reactions are of two types, namely the complete and the incomplete. - whereas the complete antibodies agglutinate red cells in saline medium, the incomplete
More informationDARATUMUMAB HARD TO PRONOUNCE - EVEN HARDER ON BLOOD BANK TESTING. Dr. Jennifer Duncan Hematopathology Resident March 18, 2017
DARATUMUMAB HARD TO PRONOUNCE - EVEN HARDER ON BLOOD BANK TESTING Dr. Jennifer Duncan Hematopathology Resident March 18, 2017 Goals and Objectives: Briefly describe the use of dara in the treatment of
More informationRequirements of IBTO (AABB) Standards d for a Blood Transfusion Request 1.Positive identification of the recipient and the recipient blood samples.
Detection and Identification of alloantibodies to Red Cell Antigens Antibody Screen Test Iranian Blood Transfusion Organization Mostafa Moghaddam MS, CLS ( ASCP ) BB Head of Immunohematology Reference
More informationBlood Bank Review. Case #1 ABO/Rh. Case #1 Antibody Screen. Is the ABO grouping discrepant? No Interpretation: O positive
Blood Bank Review Mary Burroughs Blood Bank Technical Specialist Mercy Health Saint Mary s Case #1 ABO/Rh Forward Grouping Reverse Grouping Anti-A Anti-B Anti-D A1 cells B cells 0 0 3+ 4+ 4+ Is the ABO
More informationImmunohematology Practicum Objectives - CLS 645
Clinical Laboratory Sciences Department University of Kansas Medical Center Immunohematology Practicum Objectives - CLS 645 The following objectives are to be completed by the student for successful completion
More informationSusan T. Johnson, MSTM, MT(ASCP)SBB BloodCenter of Wisconsin Milwaukee, WI USA
Laboratory Investigation of Hemolytic Transfusion Reactions Speaker Professor A Pourazar Susan T Johnson, MSTM, MT(ASCP)SBB BloodCenter of Wisconsin Milwaukee, WI USA Laboratory Evaluation of Transfusion
More informationSerological Testing: Why we did what we did!
Serological Testing: Why we did what we did! W. John Judd, FIBMS, MIBiol Emeritus Professor University of Michigan What we did Provided blood and blood products in a timely, cost-efficient manner. Implemented
More informationDefinitions. Absorption/Adsorption and Elution. Elution. CLS 422 Clinical Immunohematology I Absorption and Elution 1
Definitions Absorption/Adsorption and Elution CLS 422 Clinical Immunohematology I Absorption: To remove antibodies from serum through the action of the target antigen. Adsorption: The uptake of antibody
More informationTools and Strategies Useful for Antibody Identification. Virginia Hare, MT(ASCP)SBB Immunohematology Reference Lab American Red Cross Southern Region
Tools and Strategies Useful for Antibody Identification Virginia Hare, MT(ASCP)SBB Immunohematology Reference Lab American Red Cross Southern Region 1 st case: 85 y.o. white female Admitted for a total
More informationSerological Tools For Investigating Problems In Immunohaematology
Serological Tools For Investigating Problems In Immunohaematology Dr.K.Vasantha Deputy Director (Retd.) National Institute of Immunohaematology (ICMR) Parel, Mumbai Immunohaematology is an application
More informationSPECIALIST IN BLOOD BANKING EXPERIENCE DOCUMENTATION FORM (Routes 2, 3 & 4)
PART I (To be completed by Applicant) SPECIALIST IN BLOOD BANKING EXPERIENCE DOCUMENTATION FORM (Routes 2, 3 & 4) Applicant s Name Last Four Digits of Applicant s Social Security # Address E-mail Address
More informationVIII. Pretransfusion Compatibility Testing
VIII. Pretransfusion Compatibility Testing A. The purpose of pretransfusion testing is to select, for each recipient, blood components that, when transfused, will have acceptable survival and will not
More informationVII. Rh Blood Group System
VII. Rh Blood Group System A. The Rh system is one of the most complex genetic systems, and certain aspects of its genetics, nomenclature and antigenic interactions are unsettled. The aim of this lecture
More informationINTERNATIONAL SPECIALIST IN BLOOD BANKING WORK EXPERIENCE DOCUMENTATION FORM (Routes 2 & 3)
PART I (TO BE COMPLETED BY APPLICANT) Applicant s Name Address Email Address PART II (MUST BE COMPLETED AND SIGNED BY LABORATORY MANAGEMENT* OR EMPLOYER IN ORDER TO BE ACCEPTABLE) SUBJECT: VERIFICATION
More informationDTT Treated Reagent Red Cells for use in Resolving DARA Interference. More Than Just Kell?? Marilyn Stewart MT(ASCP)SBB
DTT Treated Reagent Red Cells for use in Resolving DARA Interference More Than Just Kell?? Marilyn Stewart MT(ASCP)SBB Daratumumab Anti-myeloma and anti-lymphoma agent known to interfere with routine Blood
More informationINTERNATIONAL SPECIALIST IN BLOOD BANKING WORK EXPERIENCE DOCUMENTATION FORM (Routes 2 & 3)
PART I (TO BE COMPLETED BY APPLICANT) Applicant s Name Address Email Address PART II (MUST BE COMPLETED AND SIGNED BY LABORATORY MANAGEMENT* OR EMPLOYER IN ORDER TO BE ACCEPTABLE) SUBJECT: VERIFICATION
More informationWe are actually talking about the Rh Blood Group System!
hr Problems Is this a discussion of your Human Resources nightmares? We are actually talking about the Rh Blood Group System! hr Problems 1 Hr and hr Antigens Hr o (Rh17) Hr or Hr S (Rh18) Hr B (Rh34)
More informationSPECIALIST IN BLOOD BANKING WORK EXPERIENCE DOCUMENTATION FORM (Routes 2, 3, & 4)
PART I (TO BE COMPLETED BY APPLICANT) Applicant s Name Last Four Digits of Applicant s Social Security # Address Email Address Daytime Telephone Number PART II (MUST BE COMPLETED AND SIGNED BY THE IMMEDIATE
More informationSPECIALIST IN BLOOD BANKING WORK EXPERIENCE DOCUMENTATION FORM (Routes 2, 3, & 4)
PART I (TO BE COMPLETED BY APPLICANT) Applicant s Name Last Four Digits of Applicant s Social Security # Address Email Address Daytime Telephone Number PART II (MUST BE COMPLETED AND SIGNED BY THE IMMEDIATE
More informationExpertise. Specialty Products Complete the puzzle with the industry s most comprehensive line of products for transfusion diagnostics.
Expertise. Specialty Products Complete the puzzle with the industry s most comprehensive line of products for transfusion diagnostics. For 30 years, Immucor has been a dedicated partner to your Blood Bank
More informationImmunohematology Review: Help, What Do I Need to Know to Pass the ASCP Exam?
Immunohematology Review: Help, What Do I Need to Know to Pass the ASCP Exam? Dr. Phyllis Ingham EdD. MEd. MT(ASCP) Program Director/Chair Clinical Laboratory Technology West Georgia Technical College Phyllis.ingham@westgatech.edu
More informationFor order enquiries. Telephone Fax For technical information
Sanquin is responsible for safe and efficient blood supply in the Netherlands on a not-for-profit basis. Sanquin also develops and produces pharmaceutical products, conducts high-quality scientific research,
More informationRed cell alloantibodies
17 Identification of Alloantibodies to Red Cell Antigens Red cell alloantibodies other than non-red-cell-stimulated anti-a or -B are called unexpected red cell alloantibodies and may be found in 0.3-38%
More informationT activation Thomsen-Friedenreich Antigen
Thomsen-Friedenreich Antigen Karen Rubio MT (ASCP) Lead Technologist Children s Mercy Hospital Blood Bank HAABB 2014 T activiation British Journal of Haematology, 2001, 112, 259-263 In vitro polyagglutination
More informationDiscussion. Principle. Laboratory Procedure Manual EXERCISE 3. Blaney, Chapter 4 The ABO and H Blood Group Systems. Textbook: 20 points.
Exercise 3 ABO and D Typing Textbook: Blaney, Chapter 4 The ABO and H Blood Group Systems Skills: 20 points Objectives 1. Explain why the ABO blood groups are the most significant of all blood group systems.
More informationFinding Strength in Weak Reactions. Raeann Thomas, MLS(ASCP) CM Blood Bank Supervisor Hospital of the University of Pennsylvania
Finding Strength in Weak Reactions Raeann Thomas, MLS(ASCP) CM Blood Bank Supervisor Hospital of the University of Pennsylvania November 30, 2016 Objectives Describe how antibody resolution work-flow at
More informationSerological Interference Caused by Monoclonal Antibody Drug Therapy
Serological Interference Caused by Monoclonal Antibody Drug Therapy Presented by: Christina Barron, MT(ASCP)SBB Prepared by: Christina Barron, MT(ASCP)SBB Monica A. Keith MS, BB(ASCP) Kelly Kezeor MT(ASCP)
More informationApplicable To Employees of the Gundersen Palmer Lutheran Hospitals and Clinics laboratories.
Subject ABO Forward Grouping - D Antigen Typing - Palmer Index Number Lab-8791 Section Laboratory Subsection Regional/Affiliates Category Departmental Contact Betty Tilleraas Last Revised 10/31/2017 References
More informationAcceptable Student Result Range Identify with 100% accuracy any alloantibody in a patient serum sample.
Name Panel Studies Principle If positive reactions (agglutination and/or hemolysis) are obtained at any phase of the antibody screen or crossmatch procedure, a panel study must be performed. Positive reactions
More informationResolve Panel A A Qualitative Test for the Identification of Unexpected Blood Group Antibodies
Revised October 2015 Reagent Red Blood Cells Resolve Panel A A Qualitative Test for the Identification of Unexpected Blood Group Antibodies 719510 Rx ONLY SUMMARY AND EXPLANATION When an unexpected antibody
More informationMolecular Analysis of Automated Phenotype Discrepancies among Blood Donors
Molecular Analysis of Automated Phenotype Discrepancies among Blood Donors Greg Denomme, PhD Director of Immunohematology & Transfusion Services BloodCenter of Wisconsin Objectives Review how licensed
More informationCombining Serology and Genotyping to Improve Patient Outcomes: Case Studies
Combining Serology and Genotyping to Improve Patient Outcomes: Case Studies Lauro E. Guerra, Jr., BS, MLS(ASCP) CM SBB CM Manager, Grifols Immunohematology Center, San Marcos, TX, USA March 22, 2019 Objectives
More informationImmunohematology Case Studies PD Dr. med. Franz F Wagner Red Cross Blood Service NSTOB
Immunohematology Case Studies 2016-5 PD Dr. med. Franz F Wagner Red Cross Blood Service NSTOB fwagner@bsd-nstob.de Clinical History A 78 yrs old patient had coronary artery bypass surgery. In the perioperative
More information3/3/2013. Reference Lab Case Studies
Reference Lab Case Studies Virginia Hare, MT(ASCP)SBB American Red Cross Southern Region Douglasville, Georgia Today s Cases and Presenters Rh typing discrepancy by Grace Lee An Unusual Phenotype: Getting
More informationReference Lab Case Studies. Virginia Hare, MT(ASCP)SBB American Red Cross Southern Region Douglasville, Georgia
Reference Lab Case Studies Virginia Hare, MT(ASCP)SBB American Red Cross Southern Region Douglasville, Georgia Today s Cases and Presenters Rh typing discrepancy by Grace Lee An Unusual Phenotype: Getting
More informationDIAGNOSTIC SERVICES BC & YUKON
DIAGNOSTIC SERVICES BC & YUKON YEAR IN REVIEW JANUARY - DECEMBER 31, 2012 Page 1 of 23 CANADIAN BLOOD SERVICES BC & YUKON DIAGNOSTIC SERVICES SENIOR STAFF AND CONTACT INFORMATION Medical Director (604)
More informationSanquin Blood Grouping Reagents
Sanquin Blood Grouping Reagents Blood grouping reagents are essential tools for diagnostic laboratories specialised in serology. The broad range of reagents developed by Sanquin Reagents is used in several
More informationImmunohematology A Student Review
Immunohematology A Student Review Scott C. Wise, MS, MT(ASCP)SBB Associate Professor, Georgia Regents University American Society for Clinical Laboratory Science Georgia 2015 Annual Meeting May 16, 2015
More informationIs it time to re-evaluate the gold standard in red cell antigen typing?
Is it time to re-evaluate the gold standard in red cell antigen typing? Susan T. Johnson, MSTM, MT(ASCP)SBB American Society of Clinical Laboratory Science Central New England May 9, 2013 161 GLOBCC 8MAY2015
More informationCURRENT COURSE OFFERINGS
The American Red Cross offers regular educational opportunities as a convenient way for healthcare providers to receive relevant blood banking and transfusion medicine information. The bi-monthly sessions,
More information4/12/2019. Handouts Advanced Track Webinars. us/pages/educational Program Handouts.aspx
Handouts http://www.immucor.com/en us/pages/educational Program Handouts.aspx 2 All Content Immucor, Inc. 2019 Advanced Track Webinars Link to register: https://immucor.webinato.com/register 3 All Content
More informationBLOOD TYPING REAGENTS. Product Profile
BLOOD TYPING REAGENTS Product Profile 2 BLOOD TYPING REAGENTS Its all about Human Blood Human blood is classified based on presence or absence of inherited antigens on the surface of red blood cells (RBCs).
More informationBlood Grouping Reagent IH-Anti-D (RH1) Blend
Blood Grouping Reagent IH-Anti-D (RH1) Blend English, B186530, Version 07, 2018.11 FOR IN VITRO DIAGNOSTIC USE Anti-D reagent for use with IH-System MEETS FDA POTENCY REQUIREMENTS U.S. License Number:
More informationFORENSIC SEROLOGY. Chapter PRENTICE HALL 2008 Pearson Education, Inc. Upper Saddle River, NJ 07458
Chapter 8 FORENSIC SEROLOGY 8-1 Nature of Blood The word blood refers to a highly complex mixture of cells, enzymes, proteins, and inorganic substances. Plasma, which is the fluid portion of blood, is
More informationDIAGNOSTIC SERVICES BC & YUKON
DIAGNOSTIC SERVICES BC & YUKON YEAR IN REVIEW JANUARY - DECEMBER 31, 2013 Page 1 of 23 CANADIAN BLOOD SERVICES BC & YUKON DIAGNOSTIC SERVICES SENIOR STAFF AND CONTACT INFORMATION Associate Medical Director,
More informationWhen, autoimmune hemolytic anemia
IMMUNOHEMATOLOGY Adsorption of autoantibodies in the presence of LISS to detect alloantibodies underlying warm autoantibodies Jacques Chiaroni, Mohammed Touinssi, Magali Mazet, Philippe de Micco, and Virginie
More informationSTANDARD OPERATING PROCEDURE FOR QUALITY CONTROL OF REAGENTS AND ANTISERA
STANDARD OPERATING PROCEDURE FOR QUALITY CONTROL OF REAGENTS AND ANTISERA TITLE: STANDARD OPERATING PROCEDURE FOR QUALITY CONTROL OF REAGENTS AND ANTISERA 1.0 Principle 1.1 The purpose of quality control
More informationRx ONLY
Blood Grouping Reagent Anti-D (Anti-Rh o ) (Human Monoclonal-Polyclonal Blend) BioClone For Rapid Tube, Slide and Microplate Tests Qualitative Test for Recognition of the D(Rh o ) Antigen on Human Red
More informationINSTRUCTIONS FOR USE. BLOOD GROUPING REAGENT ORTHO Sera Anti-Le a (Anti-LE1) ORTHO Sera Anti-Le b (Anti-LE2)
BLOOD GROUPING REAGENT ORTHO Sera Anti-Le a (Anti-LE1) ORTHO Sera Anti-Le b (Anti-LE2) 6904497 6904498 Intended Use For in vitro diagnostic use only For Direct Agglutination Test by Column Agglutination
More informationROLE OF MOLECULAR GENOTYPING IN TRANSFUSION MEDICINE
ROLE OF MOLECULAR GENOTYPING IN TRANSFUSION MEDICINE Dr.( Prof.) R.N. Makroo Director and Sr. Consultant Dept. of Blood Transfusion Medicine, Molecular Biology & Transplant Immunology Indraprastha Apollo
More informationTherapeutic monoclonal antibodies & blood transfusion Essential information for hospital transfusion laboratories, transfusion practitioners &
Therapeutic monoclonal antibodies & blood transfusion Essential information for hospital transfusion laboratories, transfusion practitioners & haematology clinical teams March 2018 Background Targeted
More informationAntibodies and Antigens in the Blood Bank 9/7/2015 NAHLA BAKHAMIS 1
Antibodies and Antigens in the Blood Bank NAHLA BAKHAMIS 9/7/2015 NAHLA BAKHAMIS 1 Outline Antibodies structure, classes and functions Most important Abs in the blood bank effective roles of Abs Zeta potential
More informationPRODUCT CATALOG. Immunohematology.
PRODUCT CATALOG Immunohematology www.biognost.com Complete dedication to science Fulfilling our ambition - first to detect, develop, and offer solutions Our everyday business is shaped by clear missions,
More informationPretransfusion Testing
16 Pretransfusion Testing The purpose of pretransfusion testing is to select blood components that will have acceptable survival when transfused and will not cause harm to the recipient. If performed properly,
More informationTHANK YOU FOR SAVING MY LIFE
THANK YOU FOR SAVING MY LIFE Importance of blood typing Transfusion has taken an increasingly important role in the life support of canine and feline patients. Thus, the need for quick and accurate blood
More informationOriginal Equipment Manufacturing. Intermediate and OEM Products for Immunohaematology
Original Equipment Manufacturing Intermediate and OEM Products for Immunohaematology A long history as an OEM manufacturer For over 30 years, Quotient has developed, manufactured and marketed high quality
More informationDIAGNOSTIC SERVICES BRITISH COLUMBIA / YUKON YEAR IN REVIEW JANUARY DECEMBER 2014
DIAGNOSTIC SERVICES BRITISH COLUMBIA / YUKON YEAR IN REVIEW JANUARY DECEMBER 2014 Year in Review statistics are based on a January to December calendar year. The calendar year provides better correlation
More informationObservations for UK NEQAS (BTLP) data. Jenny White Deputy Scheme Manager (BTLP)
Observations for UK NEQAS (BTLP) data Jenny White Deputy Scheme Manager (BTLP) UK NEQAS Q data 2016 Technology used for routine G+S Inherent differences in IAT technology Solid phase Easy to automate Adherence
More informationAntibodies and Antigens In the blood bank
Antibodies and Antigens In the blood bank 1 Nice game!! http://nobelprize.org/ 2 Karl Landsteiner discovered blood groups in 1901. Awarded Nobel Prize for Physiology or Medicine in 1930 3 Why we study
More informationBlood Grouping Reagent IH-Card Group ABO A-B-A-B-A-B
Blood Grouping Reagent IH-Card Group ABO A-B-A-B-A-B English, B186363, Version 06, 2017.03 FOR IN VITRO DIAGNOSTIC USE Gel card for use with the IH-System MEETS FDA POTENCY REQUIREMENTS U.S. LICENSE NUMBER:
More informationGUIDELINES FOR PRETRANSFUSION TESTING : PART I
Commissie voor Klinische Biologie Commission de Biologie Clinique GUIDELINES FOR PRETRANSFUSION TESTING : PART I Dr. A. Vanhonsebrouck, Bloedtransfusiecentrum Antwerpen 26-03-2009 WIV congress Rue Juliette
More informationGEL CARD AND SALINE TUBE TECHNIQUES FOR BLOOD CROSS MATCHING: A COMPARATIVE ASSESSMENT
GEL CARD AND SALINE TUBE TECHNIQUES FOR BLOOD CROSS MATCHING: A COMPARATIVE ASSESSMENT Mahamat Ahmat Aboussakine 1, Dr. Kalpana Sankhala 2 1 MSc Blood Transfusion Technologym. NIMS University,Jaipur Rajasthan,
More informationBLOOD BANK PROCEDURES
6 T H ANNUAL WORKSHOP HEMATOLOGY AND BLOOD TRANSFUSION 05 09 MUHARRAM 1424 (08-12 MARCH 2003) BLOOD BANK PROCEDURES TABLE OF CONTENTS Specimen Receipt 1-5 Grading of Agglutination Reactions 6-8 Reagent
More informationBlood Grouping Reagent IH-Card ABO/D(DVI-)+Rev A1, B A-B-D(DVI-)-ctl-Neutral-Neutral
Blood Grouping Reagent IH-Card ABO/D(DVI-)+Rev A1, B A-B-D(DVI-)-ctl-Neutral-Neutral English, B186350, Version 07, 2017.12 FOR IN VITRO DIAGNOSTIC USE Gel card for use with the IH-System MEETS FDA POTENCY
More informationWorking Experience with Solid Phase Antibody Detection Technique
Rounds [Blood Bank/Transfusion Medicine] Working Experience with Solid Phase Antibody Detection Technique Anjali A. Satoskar, MD, David Krugh, MT(ASCP)SBB, CLS(NCA), Melanie S. Kennedy, MD Department of
More informationBIOSCOT Blood Typing Monoclonal Reagents
BIOSCOT Blood Typing Monoclonal Reagents Merck Millipore, your partner for monoclonal blood typing diagnostics For over 25 years Merck Millipore has been leading the development of monoclonal antibodies
More informationType and screen policy in the blood bank: Is AHG cross-match still required? A study at a multispecialty corporate hospital in India
Original Article Type and screen policy in the blood bank: Is AHG cross-match still required? A study at a multispecialty corporate hospital in India Sangeeta Pathak, M. Chandrashekhar 1, G. R. Wankhede
More informationABO, Rh, HLA Antibodies Issues with Whole Blood NANCY M. DUNBAR, MD MEDICAL DIRECTOR, BLOOD BANK DARTMOUTH-HITCHCOCK MEDICAL CENTER, LEBANON, NH, USA
ABO, Rh, HLA Antibodies Issues with Whole Blood NANCY M. DUNBAR, MD MEDICAL DIRECTOR, BLOOD BANK DARTMOUTH-HITCHCOCK MEDICAL CENTER, LEBANON, NH, USA The Appeal of Whole Blood WHOLE BLOOD IN EXSANGUINATING
More informationNHS Blood and Transplant Reagents. Meeting your serology needs
NHS Blood and Transplant Reagents Meeting your serology needs NHSBT Reagents meet your serology needs by manufacturing a portfolio of transfusion related diagnostic reagents, supporting our commercial
More informationPOL:07:QP:010:03:NIBT PAGE: 1 of 4. Document Details Document Number: POL:07:QP:010:03:NIBT No. of Appendices: 4 Supersedes Number: 07:02:QP:010:NIBT
POL:07:QP:010:03:NIBT PAGE: 1 of 4 POLICY DOCUMENT Document Details Document Number: POL:07:QP:010:03:NIBT No. of Appendices: 4 Supersedes Number: 07:02:QP:010:NIBT Document Title: INTERNAL QUALITY CONTROL
More informationWhat s in your DNA? Name: Date / Time: Event:
What s in your DNA? Name: Sunitha Vege, MS Manager, Genomics Laboratory, NYBC Date / Time: Monday, October 8, 2012 / 7:45 AM Event: AABB Boston Industry Workshop 26 GLOBCC 5OCT2014 Background 1850 s: G.
More informationGuidelines for compatibility procedures in blood transfusion laboratories
Transfusion Medicine, 2004, 14, 59 73 GUIDELINES Guidelines for compatibility procedures in blood transfusion laboratories Working Party of the British Committee for Standards in Haematology Blood Transfusion
More informationDo Donors With Non-Deletional Blood Group O Allels Boost Anti-A and Anti-B Titers in Blood Group O Recipients?
Do Donors With Non-Deletional Blood Group O Allels Boost Anti-A and Anti-B Titers in Blood Group O Recipients? E. A. Scharberg, S. Seyboth, K. Panter, A. Ernst, J. Hagel, E. Richter, G. Rink, K. Janetzko,
More informationDIAGNOSTIC SERVICES BRITISH COLUMBIA / YUKON YEAR IN REVIEW JANUARY DECEMBER 2015
DIAGNOSTIC SERVICES BRITISH COLUMBIA / YUKON YEAR IN REVIEW JANUARY DECEMBER 2015 Diagnostic Services Year in Review statistics are based on a January to December calendar year. The calendar year provides
More informationPlatelet Refractoriness: The Basics. Martin H. Bluth, MD, PhD
Platelet Refractoriness: The Basics Martin H. Bluth, MD, PhD Complete Toxicology Laboratories, LLC Objectives Define platelet refractoriness and associated conditions that may cause platelet refractoriness.
More informationABO Blood Group Discrepancies: Causes And resolution
ABO Blood Group Discrepancies: Causes And resolution Indian journal of tranffusion Medicine Introduction The ABO system contains four major ABO phenotypes: A, B, O and AB. The four phenotypes are determined
More informationUsing EQA to improve practice - highlights 2017/18. Richard Haggas UK NEQAS Blood Transfusion Laboratory Practice
Using EQA to improve practice - highlights 2017/18 Richard Haggas UK NEQAS Blood Transfusion Laboratory Practice BTLP Reports - Look at the front sheet - No penalties - May look to the graphs BTLP Reports
More informationDr Priti Elhence, Professor Dept of Transfusion Medicine, SGPGIMS MD (Transfusion Medicine), SGPGI Sr Residency Faculty Since 2000
CV Dr Priti Elhence, Professor Dept of Transfusion Medicine, SGPGIMS MD (Transfusion Medicine), SGPGI -1991-94 Sr Residency 1994 97 Faculty Since 2000 Princess of Wale fellowship Areas of interest Immunohematology,
More informationO NO YOU DIDN T! AN ABO-MISMATCHED PLATELET TRANSFUSION
O NO YOU DIDN T! AN ABO-MISMATCHED PLATELET TRANSFUSION L A U R I E W O L F M L S ( A S C P ) S B B U N I V E R S I T Y O F K A N S A S H O S P I T A L PATIENT OVERVIEW 11-4-2011 56 y/o male with a history
More informationBlood Grouping Reagent IH-Card Group A,B A,B-A,B-A,B-A,B-A,B-A,B
Blood Grouping Reagent IH-Card Group A,B A,B-A,B-A,B-A,B-A,B-A,B English, B186352, Version 06, 2017.12 FOR IN VITRO DIAGNOSTIC USE Gel card for use with the IH-System MEETS FDA POTENCY REQUIREMENTS U.S.
More information